Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lexaria Bioscience Corp
LEXX
Alternate Symbol(s):
LEXXW
Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the...
bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LEXX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(179)
•••
ranman
X
View Profile
View Bullboard History
Comment by
ranman
on Jun 03, 2022 7:05am
RE:REMEMBER when AGpicks (eg pumper) liked lexx?
Top of the morning to all longs. Suck it to you WakeUPP LOL Nice couple of announcements this week. Way, way, way better than rodent tests I'd say.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 03, 2022 2:00am
New Press Release - Lexaria Grants Exclusive License to Premier Wellness Science Co., Ltd. for Strategic and Long-Term Partnership in the Japanese Market
Minimum payments due to Lexaria of US$4,527,500 over the first five years to retain exclusivityLexaria to receive royalty revenue from DehydraTECH product salesKELOWNA, BC / ACCESSWIRE / June 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global...
read article.
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 02, 2022 9:05am
New Press Release - Lexaria Grants License to Valcon Medical for the European Market
(TheNewswire) Contract Manufacturing Organization first in Europe to License DehydraTECHLexaria will receive milestone fees and royalty payments from product salesKelowna, British Columbia – TheNewswire - June 2, 2022 – Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:EXXW) (the “Company” or...
read article.
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Jun 01, 2022 7:22pm
IND will transform the future
Let's go on becoming the next GWPH
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 01, 2022 9:01am
New Press Release - Lexaria Announces 2022 Annual Meeting Results
KELOWNA, BC / ACCESSWIRE / June 1, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the results of the 2022 Annual Meeting (the "Meeting").On May 31, 2022 at 1:00 p.m. (Pacific Time), the Company held...
read article.
(33)
•••
WakeUPP
X
View Profile
View Bullboard History
Post by
WakeUPP
on May 31, 2022 8:53am
REMEMBER when AGpicks (eg pumper) liked lexx?
Furu A fake guru. Someone who claims to have all the knowledge and skills, but demonstrates none. Furu's are thought of as snake oil salesman or a con man.
...more
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on May 28, 2022 3:19pm
Big stuff happening
$LEXX reversal https://t.co/cZE6ecyYOG
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 26, 2022 8:30am
New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.”To hear the AudioPressRelease, please visit: The NetworkNewsAudio News PodcastTo view the full editorial...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 25, 2022 8:30am
New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space
NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing...
read article.
(1)
•••
Yowza123
X
View Profile
View Bullboard History
Post by
Yowza123
on May 17, 2022 9:24am
Lexaria update interview starts P6 of Ohashi's newsletter:
https://4495825a-d729-4d8f-ade8-e78f828e1c8d.usrfiles.com/ugd/449582_8974e903d744400a8f0bd05b703a21c3.pdf Looks like a lot of possibilities any day now :)
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on May 16, 2022 6:44pm
Great video.. If arterial stiffness can be reduced
This will be a major event for Lexaria coming IND process https://youtu.be/oJ6ebQclqHI
(179)
•••
ranman
X
View Profile
View Bullboard History
Comment by
ranman
on May 16, 2022 7:24am
RE:count
And then there's your run of the mill SH Troll. Runniing at a hot 64 (I"m being genreous)
(33)
•••
WakeUPP
X
View Profile
View Bullboard History
Post by
WakeUPP
on May 15, 2022 11:38pm
count
we have 2 idiot pumpers (skyman and agpicker pumper) and 2 dumb as a stump followers (ranman and yowza123)
(1)
•••
Yowza123
X
View Profile
View Bullboard History
Comment by
Yowza123
on May 12, 2022 3:36pm
RE:RE:im sorry
So true @ranman. Also, if you don't sell you don't take the proverbial "Bath" that Wakeup seems to be pushing. Whole market is a joke right now. Screaming great price on this stock
...more
(33)
•••
WakeUPP
X
View Profile
View Bullboard History
Comment by
WakeUPP
on May 12, 2022 11:56am
RE:RE:im sorry
you see? ranman has ridden lexx down from $12 (last year) to $2 and STILL has learned a damn thing! HOW MANY times have you done that over the last 20 years???? STILL repeating the same nonsnese
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study